Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-08

Clinical Trial Update: Retinal OCTA for Microvascular Dysfunction Evaluation and Outcome Prediction in MINOCA Patients

View source ↗

Summary

This University of Pisa trial uses retinal OCTA imaging to evaluate microvascular dysfunction and predict outcomes in MINOCA and STEMI patients and is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Pisa | Conditions: MINOCA, STEMI | Status: RECRUITING